0001209191-21-046802.txt : 20210715 0001209191-21-046802.hdr.sgml : 20210715 20210715173347 ACCESSION NUMBER: 0001209191-21-046802 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210714 FILED AS OF DATE: 20210715 DATE AS OF CHANGE: 20210715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Wendy S. CENTRAL INDEX KEY: 0001652822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40315 FILM NUMBER: 211093527 MAIL ADDRESS: STREET 1: 800 E. LEIGH STREET STREET 2: SUITE 209 CITY: RICHMOND STATE: VA ZIP: 21219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001637715 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472309515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 283-0280 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-14 0 0001637715 Reneo Pharmaceuticals, Inc. RPHM 0001652822 Johnson Wendy S. C/O RENEO PHARMACEUTICALS, INC. 12230 EL CAMINO REAL, SUITE 230 SAN DIEGO CA 92130 0 1 0 0 Chief Development Officer Common Stock 2021-07-14 4 S 0 111736 8.50 D 0 D The Reporting Person previously notified the Issuer of her intention to retire from her position as the Issuer's Chief Development Officer, effective on or before December 31, 2021. Following her announcement, the Reporting Person exercised an option totaling 111,736 shares of Common Stock of the Issuer (the "Shares") on July 8, 2021. The Reporting Person is selling the Shares privately to Abingworth Bioventures 8 LP ("Abingworth"), an existing stockholder of the Issuer. Bali Muralidhar, a Director of the Issuer, is a member of the investment committee of Abingworth. /s/ Vineet R. Jindal, Attorney-in-Fact 2021-07-14